February 2019—London-based LGC announced the acquisition of SeraCare Life Sciences.
SeraCare provides quality control materials for infectious disease testing through its Accurun reagents and next-generation sequencing reference materials through its Seraseq products for oncology, noninvasive prenatal testing, and inherited disease testing.
Its customer base includes in vitro diagnostic assay developers and manufacturers, clinical laboratories, pharmaceutical companies, and proficiency providers.
SeraCare employs 170 people and will continue to operate from its two sites in Milford, Mass., and Gaithersburg, Md., under LGC’s ownership.
LGC, +44 (0)20 8943 7000